
|Articles|September 24, 2015
Lecia V. Sequist Provides an Overview of T790M Mutations in NSCLC
Author(s)Lecia V. Sequist
Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.
Advertisement
Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene. T790M is the primary cause of treatment resistance in EGFR-positive patients with non-small cell lung cancer (NSCLC).
Advertisement
Advertisement
Advertisement
Trending on CURE
1
"You Think It Won't Happen to You" — Teddi Mellencamp on Melanoma and Speaking Up
2
Reclaim Your Strength: Simple At-Home Exercise for Cancer Patients & Survivors
3
Living with Metastatic Cancer Means Loss in the Midst of Love
4
Hair Loss, Fertility and Long-Term Health: What Parents of Kids With Cancer Need to Know
5




